Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial-Reference-Cited by-同舟云学术

Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial

Published:2022-08 Issue:8 Volume:33 Page:1569-1580
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Provenzano Michele,Puchades Maria Jesús,Garofalo Carlo,Jongs Niels,D’Marco Luis,Andreucci Michele,De Nicola Luca,Gorriz Jose Luis,Heerspink Hiddo J.L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Nephrology,General Medicine

Reference20 articles.

1. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;Perkovic;N Engl J Med,2019

2. Dapagliflozin in patients with chronic kidney disease;Heerspink;N Engl J Med,2020

3. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes;Bakris;N Engl J Med,2020

4. Cardiovascular events with finerenone in kidney disease and type 2 diabetes;Pitt;N Engl J Med,2021

5. Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A post hoc analysis from the CREDENCE Trial;Oshima;J Am Soc Nephrol,2020

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy;Clinical Kidney Journal;2024-08-12

2. Hyperkalemic effect of drug–drug interaction between esaxerenone and trimethoprim in patients with hypertension: a pilot study;Journal of Pharmaceutical Health Care and Sciences;2024-08-02

3. Sirtuin 3 in renal diseases and aging: From mechanisms to potential therapies;Pharmacological Research;2024-08

4. Dapagliflozin restores autophagy and attenuates apoptosis via the AMPK/mTOR pathway in diabetic nephropathy rats and high glucose-induced HK-2 cells;International Urology and Nephrology;2024-07-29

5. Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease;Clinical Journal of the American Society of Nephrology;2024-07-22